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Background: Notch signaling plays a crucial role in the fate determination of cochlear progenitor cells, hair cells, and
supporting cells in the developing cochlea. Recent studies have demonstrated the temporal activation of Notch
signaling in damaged mature cochleae, and have demonstrated the induction of new hair cells by pharmacologically
inhibiting Notch signaling. The present study aimed to illustrate the feasibility of pharmacologically inhibiting Notch
signaling by using a gamma-secretase inhibitor for treating sensorineural hearing loss.
Results: The effect of the sustained local delivery of MDL28170, a gamma-secretase inhibitor, on hearing and hair cell
induction was tested in a guinea pig model with noise-induced hearing loss. MDL28170 was directly delivered into the
cochlear fluids via a micro-osmotic pump. Drug application was initiated 7 days after noise exposure. Measurements of
auditory brainstem responses revealed better hearing in the MDL28170-treated animals than in the vehicle controls.
Histological analysis demonstrated a higher number of outer hair cells in the MDL28170-treated cochleae than the
vehicle-treated cochleae.
Conclusion: These findings strongly suggest that local sustained delivery of a gamma-secretase inhibitor into the
cochlea could be a novel strategy for treating acute hearing loss that is refractory to conventional treatment.
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Sensorineural hearing loss (SNHL) is a common disabil-
ity. However, in general, hearing never returns once it is
lost. There are no therapeutic options for SNHL, except
hearing aids and cochlear implantation. The mammalian
cochlea has virtually no regenerative capacity, which is a
main reason for the difficulty in treating SNHL. Indu-
cing regeneration of auditory hair cells, which convert
sound stimuli into neural signals, has been a particularly
critical issue in developing novel therapeutic strategies
for SNHL.
The Notch signaling pathway is involved in the cell fate
determination of various cell lineages [1-7]. This signaling
pathway exerts its effect when the interaction of the Notch* Correspondence: tnakagawa@ent.kuhp.kyoto-u.ac.jp
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unless otherwise stated.receptor and its ligand induces proteolytic cleavage of the
Notch receptor through gamma-secretase activity [8,9]. A
gamma-secretase inhibitor achieves pharmacological in-
hibition of Notch signaling by taking advantage of this
mechanism [10,11]. Previous studies regarding the devel-
opmental biology of the inner ear have demonstrated the
important role of Notch signaling in cell fate specification
into hair cells or supporting cells from cochlear prosen-
sory cells [12-15]. In the cochlear epithelium, the activa-
tion of Notch signaling resulted in the upregulation of
Hes1 and Hes5 leading to differentiation of progenitor
cells into supporting cells, while inactivation of Notch sig-
naling induced the expression of Atho1, which is one of
the key molecules for hair cell differentiation. Previous
studies have demonstrated that the overexpression of
Atho1 in cochlear epithelia induces hair cells fromd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ited genetically [12,15] or pharmacologically [11] during
the cochlear developmental stage, an increased number of
hair cells and a decreased number of supporting cells are
observed. Based on these observations, several studies
attempted the induction of new hair cells in the postnatal
stage when the cell fate specification has already ceased
[10,20]. Genetic and pharmacological inhibition of Notch
signaling causes ectopic hair cell induction in the neonatal
mouse cochlea [10]. Moreover, a recent report has shown
that the pharmacological inhibition of Notch signaling in-
duces the generation of new hair cells, even in mature
mouse cochleae, by the transdifferentiation of supporting
cells [20].
Based on findings in explant cultures of neonatal
mouse cochleae [10], we previously examined the poten-
tial of MDL28170 (MDL), a gamma-secretase inhibitor,
for the induction of new hair cells in adult guinea pig
cochleae in vivo [21]. In that study, an ototoxic treat-
ment that caused the total loss of the outer hair cells
was used to aid the identification of newly generated
hair cells. As a result, the induction of new hair cells
was identified, although their number was limited. The
severe degeneration of supporting cells (a source of
newly generated hair cells) may be the reason for the poor
induction of new hair cells. On the other hand, single ap-
plication of the gamma-secretase inhibitor LY411575 into
the middle ear was recently tested in a mouse model with
noise-induced hearing loss; the treatment resulted in the
induction of new hair cells and in hearing recovery [20].
However, a high activity of LY411575 for the inhibition of
Notch signaling involves a risk of adverse events, in par-
ticular promotion of malignancies [22]. Therefore, as an
alternative for LY411575, a gamma-secretase inhibitor
with moderate, but sufficient, activity for the inhibition of
Notch signaling is needed for clinical application.
The present study aimed to test the potential of sus-
tained local delivery of MDL into cochlear fluids for the
induction of new hair cells and the recovery of hearing
in a guinea pig model with a previously established
noise-induced hearing loss [23]. In this model, apoptosis
of the outer hair cells in selective regions of the cochlea
occurred within 5 days after the noise exposure; the sup-
porting cells were preserved [23]. To examine the poten-
tial of inducing new hair cells after hair cell loss, local
application of MDL was initiated 7 days after the noise
exposure [23]. For the sustained delivery of MDL, a
micro-osmotic pump was used, as described in previous
studies [21,23]. In the present study, the MDL-treated ani-
mals exhibited better hearing than the vehicle control ani-
mals and had higher numbers of outer hair cells in the
cochleae than the vehicle control animals. These findings
strongly suggest the potential of gamma-secretase inhibi-
tors as therapeutics for the treatment of SNHL.Methods
Animals
Hartley strain guinea pigs weighing 350–400 g were pur-
chased from Japan SLC, Inc. (Hamamatsu, Japan). The
Animal Research Committee of the Graduate School of
Medicine at Kyoto University approved all experimental
protocols. Animal care was supervised by the Institute of
Laboratory Animals of the Graduate School of Medicine
at Kyoto University. All experimental procedures were
performed in accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory
Animals. All efforts were made to limit the number of
animals used and their suffering.
Noise exposure
Guinea pigs were exposed to a continuous pure tone at
6 kHz with a 130-dB SPL for 15 min under general
anesthesia [23]. Each animal was immobilized in a non-
invasive head holder. A speaker was positioned 10 cm in
front of the animal’s head. Sound levels were monitored
using a 1/2 inch condenser microphone (Sony, Tokyo,
Japan) and a fast Fourier transform analyzer (Sony).
To clarify the cochlear damage before the drug appli-
cation, cochlear specimens (n = 4) were collected on day
7 and were processed histologically.
To determine noise-induced damage, ABR recording
was performed 7 days after noise exposure. Animals
showing 40 dB and larger ABR threshold shifts in both
ears and smaller than 10 dB differences in threshold
shifts between left and right ears were provided follow-
ing experiments. To determine symmetrical lesions in
both ears of animals that matched this condition, we
compared hair cell numbers in left ears with those of
right ears (n = 4).
Local drug application
On day 7 after the noise exposure, the gamma-secretase
inhibitor MDL (Sigma-Aldrich, St. Louis, MI) was locally
applied to the perilymph. Under general anesthesia, a
cochleostomy was performed 1 mm from the edge of the
round window on the basal turn of the cochlea. A
Tefron tube with an inner diameter of 180-μm (UT-03,
Unique Medical Co., Ltd., Tokyo, Japan) was connected
to a micro-osmotic pump (Alzet, Cupertino, CA) and
inserted into the scala tympani of the basal turn of the
left cochlea of each guinea pig. The mini pump pumped
MDL at a rate of 0.25 μL/h for 14 days. The tip of a
Tefrone tube positioned at distance of 3 mm from the
round window membrane, which accords with the 85%
region from the cochlea apex [24], in order to deliver
MDL to a damaged region, 70–80% region from the
apex securely.
The MDL was dissolved in dimethyl sulfoxide (DMSO)
and diluted with a phosphate buffered saline (PBS) to
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DMSO. This concentration was also used in our previ-
ous work [21]. For 14 days, the MDL solution was con-
tinuously injected through the micro-osmotic pump into
the left cochlea of the guinea pigs (n = 7). The control
animals (n = 5) received PBS (instead of MDL solution)
into the left cochlea; the PBS contained 0.3% DMSO. In
addition, to examine the effects of MDL treatment on
the normal cochlear epithelia of mature guinea pigs,
normal guinea pigs (n = 3) received local a MDL applica-
tion through the micro-osmotic pump.
To examine cell proliferation in the cochlear sensory
epithelium by MDL treatment, the assay for labeling
with 5-ethynyl-2′-deoxyuridine (EdU) was performed.
EdU (Click-iT® EdU Imaging Kits, Molecular Probe,
Eugene, OR) was added to the MDL solution (n = 4) or
the vehicle solution (n = 4). The final concentration of
EdU was 10 μM.
Functional assessments
Auditory function was assessed by recording auditory
brainstem responses (ABRs) and distortion-product oto-
acoustic emissions (DPOAEs). The baseline ABR thresh-
olds were measured within 7 days before the noise
exposure. The ABR thresholds were measured at fre-
quencies of 8, 10 and 12 kHz, which correspond to the
regions damaged by noise trauma used in this study
[24]. The animals were anesthetized with an intramuscu-
lar injection of midazolam (10 mg/kg) and an intramus-
cular injection of xylazine (10 mg/kg). They were kept
warm with a heating pad. The generation of acoustic
stimuli and the subsequent recording of evoked poten-
tials were performed using the Powerlab/4sp data acqui-
sition system (ADInstruments, Colorado Springs, CO,
USA), as described in our previous study [25]. Acoustic
stimuli, consisting of tone-burst stimuli (0.1 ms cos 2
rise/fall and 1-ms plateau), were delivered monaurally
through a speaker (ES1spc; Bioresearch Center, Nagoya,
Japan) connected to a funnel fitted into the external
auditory meatus. The thresholds were determined from
a set of responses at varying intensities with 5-dB sound
pressure level (SPL) intervals. The electrical signals were
averaged over 1024 repetitions. The thresholds at each
frequency were verified at least twice. ABR recordings
were performed 14 days after drug application. In com-
parison ABR threshold shifts in MDL-treated cochleae
with those in vehicle-treated cochleae, values that ABR
threshold shifts in drug-treated cochleae (left) were sub-
tracted those of contralateral cochleae (right) to reduce
influences due to individual differences.
DPOAE recordings were made with an acoustic probe
(ER-10C; Etymotic Research, Elk Grove Village, IL) using
the DP2000 DPOAE measurement system version 3.0
(Starkey Laboratory, Eden Prairie, MN) before sacrifice.Two primary tones with an f2/f1 ratio of 1.2 were pre-
sented at intensity levels of 65 dB SPL (L1) and 55 dB
SPL (L2). The f2 was varied in one-ninth-octave steps
from 8 to 12 kHz. A peak at 2f1–f2 in the spectrum was
recognized as a DPOAE. The DP/noise floor (NF) levels
were calculated.
Histological analysis
On day 14 after drug application, the Tefron tube was gen-
tly removed from the cochlea under general anesthesia.
Finally, MDL-treated (n = 3), vehicle-treated (n = 3), MDL+
EdU-treated (n = 3) and vehicle + EdU treated cochleae
(n = 3) were obtained. After removing the stapes from
the oval window, followed by opening the cochlear
apex, 4% of paraformaldehyde in PBS was perfused into
the cochlea. The excised cochleae were then immersed
in the same fixative at 4°C for 12 h. After decalcifica-
tion with 0.1 M ethylenediaminetetraacetic acid for
14 days at 4°C, the cochleae were subjected to histo-
logical analysis of whole mounts. The cochlear speci-
mens were permeabilized in 0.2% Triton X in PBS for
30 min at room temperature. To determine the location
of the hair cells, immunohistochemistry was performed
for myosin VIIa (anti-myosin VIIa rabbit polyclonal
antibody; 1:500; Proteus Bioscience Inc., Romana, CA)
and F-actin labeling by fluorescein-phalloidin (1:400;
Molecular Probes). At the end of the staining proce-
dures, nuclear staining was performed with 1 μg/mL of
4′,6-diamidino-2-phenylindole (DAPI) (Molecular Probes)
in PBS. For an EdU assay, a Click-iT® EdU Imaging Kit
(Molecular Probes) was used. Staining was performed
according to the supplier’s direction followed by immuno-
staining for myosin VIIa and DAPI staining. Specimens
were viewed with a Leica TCS SP2 confocal microscope
(Leica Microsystems Inc., Wetzlar, Germany).
Cell counts
Quantitative analyses for hair cell numbers were per-
formed in the 70–80% region from the apex of the coch-
lea. The cells that were positive for myosin VIIa with
phalloidin-labeled stereocilia and DAPI-positive nuclei
were defined as surviving hair cells. The number of inner
hair cells and outer hair cells was counted respectively.
Considering individual differences between animals, we
subtracted hair cell numbers of right cochleae from those
of left cochleae that were locally applied drugs.
Statistical analyses
An unpaired t-test (one-tailed) was used to compare dif-
ferences between the groups, and a paired t-test (one-
tailed) was used for comparisons between left and right
cochleae. The data are presented in the text and figures
as the mean ± the standard error of the mean (SEM). A
p value less than 0.05 was considered significant.
Figure 1 Functional and histological damage in guinea pig cochleae by noise exposure. A: ABR threshold shifts 20 min and 7 days after
noise exposure in guinea pigs (n = 4). B: F-actin labeling with phalloidin in cochlear epithelia in the 50–60%, 70–80% and 90–95% regions from
the cochlear apex. Brackets indicate the location of the outer hair cells. A square of dotted lines shows a patch of severe hair cell loss. C: The
percent loss of hair cells in the inner hair cells (IHC), or in the first row (OHC1), second row (OHC2), or third row (OHC3) of the outer hair cells in
the 70–80% region of cochlear epithelia from the apex.
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Noise-induced damage
Noise exposure used in this study was expected to induce
selective loss of outer hair cells in the 70–80% region from
the apex of the guinea pig cochlea, as previously described
[23]. To test the reproducibility of hair cell loss in the
present study, cochlear specimens obtained on day 7 after
the noise exposure were examined histologically (n = 4).
In the 50–60% region from the apex of cochleae, only a
scattered loss of outer hair cells was identified, but the
inner hair cells were well preserved (Figure 1). In the
90–95% region from the apex of the cochlea, the inner
and outer hair cells were well preserved (Figure 1). On theFigure 2 Comparison of hair cell numbers in left and right ears of an
numbers of outer (OHC) and inner hair cells (IHC) were nearly symmetrical
of OHC or IHC between left (L) and right (R) ears with paired t-test.other hand, as we expected, a massive loss of outer hair
cells was detected in the 70–80% region from the apex of
the cochleae (Figure 1). There was one patch or two
patches of severe outer hair cell loss surrounded by areas
of scattered outer hair cell loss (Figure 1). This pattern of
hair cell loss is almost identical to previous findings by
using the same noise exposure [23].
On day 7 after noise exposure, hair cell numbers of the
left cochleae were compared with those of the right coch-
leae in four animals matched the criteria for hearing loss
(Figure 2). The lesions were almost symmetrical in both
sides. There were no significant differences in numbers of
inner or outer hair cells between left and right cochleae.imals matched ABR criteria for noise-induced damage. Remaining
in both ears (n = 4). There were no significant differences in numbers
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We measured the ABR threshold shifts at frequencies of
8 kHz, 10 kHz and 12 kHz, because these frequencies
correspond to the 70–80% region from the apex of the
guinea pig cochlea [24]. ABR threshold shifts in drug-
treated cochleae (left) were subtracted those of con-
tralateral cochleae (right) to reduce influences due to
individual differences, which were defined as corrected
ABR threshold shifts. We compared corrected ABR
threshold shifts between MDL- and vehicle treated
cochleae (Figure 3). At 12 kHz, MDL-treated cochleaeFigure 3 ABR threshold shifts compared with contralateral ears
in MDL- and vehicle-treated animals. ABR threshold shifts of
MDL- or vehicle-treated ears subtracted those of contralateral ears
are represented. Bars represent SEM. Differences in ABR threshold
shifts between MDL- (n = 3) and vehicle-treated (n = 3) ears are
statistically significant at p < 0.05 with unpaired t-test at 12 kHz (*).exhibited significantly smaller ABR threshold shifts
than vehicle-treated cochleae (unpaired t-test, p = 0.04).
DPOAEs
DPOAE measurements were performed 14 days after drug
application. DP/NF levels in MDL- and vehicle-treated an-
imals are shown in Figure 4. No significant differences in
DP/NF levels between left and right ears in either group,
or between MDL- and vehicle-treated cochleae.
Histology of cochlear epithelia
In both MDL- and vehicle-treated animals, inner hair
cells were well preserved in both ears (Figure 5A, B).
There were no significant differences in numbers of
inner hair cells between left and right ears in MDL- or
vehicle-treated animals, and between MDL- and vehicle-
treated cochleae. In contrast to inner hair cells, degener-
ation of outer hair cells was found in all specimens. One
of three animals treated with MDL exhibited extensive
loss of outer hair cells (Figure 3B). In vehicle-treated coch-
leae, all specimens showed severe loss of outer hair cells,
while in contralateral cochleae, outer hair cells were com-
paratively well preserved (Figure 3D). The difference in
numbers of outer hair cells between left and right ears
in vehicle-treated animals was significant (paired t-test,
p = 0.02). We compared degeneration of outer hair cells
in MDL-treated cochleae with that in vehicle-treated
cochleae using subtraction differences in numbers of outer
hair cells between drug-treated and contralateral cochleae
(Figure 5E). Corrected numbers of outer hair cells in
MDL-treated cochleae were significantly higher than those
in vehicle-treated cochleae (unpaired t-test, p = 0.002).
To clarify generation of new hair cells via transdiffer-
entiation of supporting cells, we examined the presence
of the cup of Deiters cell adjacent the base of outer hair
cells. In a focal plane at the apical surface of the outer
hair cell, F-actin labeling with phalloidin clearly showed
the cuticular plates of outer hair cells (Figure 6A-D).
Strong expression of myosin VIIa was also observed in
this focal plane (Figure 6A-D). Thereafter, by putting the
focal plane down to the level of the base of the outer
hair cell, the cups of Deiters cells was demonstrated by
F-actin labeling with pahlloidin, and the body of outer
hair cells was labeled with myosin VIIa (Figure 6A’-D’).
In the areas apical to severely damaged regions, exces-
sive outer hair cells were observed in MDL-treated coch-
leae (Figure 6C-D). We confirmed the presence of the
cups of Deiters cells beneath the base of outer hair cells
(Figure 6C’, D’). On the other hand, in the areas adjacent
severely damaged regions, the cups of Deiters cells were
not identified beneath the base of outer hair cells in a few
cases (Figure 6A’, B’). Consecutive observation of outer
hair cells labeled with myosin VIIa along the z-axis indi-
cated the existence of outer hair cells with long cell bodies
Figure 4 DPOAE in MDL- and vehicle-treated animals. DP/NF levels of both ears in MDL- and vehicle-treated animals are shown. X-axis shows
F2 frequency (Hz). No significant differences in DP-NF levels between left (L) and right (R) ears of MDL- or vehicle-treated animals, and between
MDL- and vehicle-treated ears.
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hair cell generation via transdifferentiation of supporting
cells in the area adjacent severely damaged regions.
For evaluation of hair cell generation through prolifera-
tion of supporting cells, we employed the EdU assay. EdU
was continuously applied to the cochlear fluid via a micro-
osmotic pump for two weeks following noise exposure.
Observation through a confocal microscope revealed the
absence of EdU-positive cells within the cochlear sensoryFigure 5 Numbers of outer hair cells in MDL- and vehicle- treated ani
cells (IHC) in left (L) and right (R) cochleae of MDL-treated animals. B: Num
C: Numbers of outer hair cells (OHC) in left (L) and right (R) cochleae of MD
of vehicle-treated animals. The difference in OHC numbers between left an
with paired t-test (*). E: Increasing numbers of OHC in MDL- and vehicle-tre
MDL- and vehicle-treated cochleae was statistically significant at p < 0.05 wepithelia of MDL- or vehicle treated cochleae, indicating
that no cell proliferation occurred in cochlear sensory epi-
thelia after noise exposure and that MDL induced no cell
proliferation on damaged cochlear sensory epithelia.
Discussion
The gamma-secretase inhibitor has gained considerable
attention because of its actions in inhibiting Notch sig-
naling and amyloid beta-peptide formation. Because of themals. Left ears were locally applied drugs. A: Numbers of inner hair
bers of IHC in left (L) and right (R) cochleae of vehicle-treated animals.
L-treated animals. D: Numbers of OHC in left (L) and right (R) cochleae
d right in vehicle-treated animals was statistically significant at p < 0.05
ated cochleae. The difference in increasing OHC numbers between
ith unpaired t-test (*).
Figure 6 Junctions between outer hair cells and Deiters cells in MDL-treated cochleae. A-D: Focal plane at the apical region of outer hair
cells. A’-D’: Focal plane at the basal portion of outer hair cells and the cups of Diters cells. In the areas adjacent severely damaged regions (A, B),
outer hair cells numbered 1 lacked junctions with the cups of Deiters cells (A’, B’), while outer hair cells numbered 2 and 3 (A’) attached to the
cups. In moderately damaged regions, excessive outer hair cells were frequently observed (C, D). Such outer hair cells (numbered 2 and 3 in C, D) were
connected with the cups of Deiters cells (C’, D’). Scale bar in A represents 20 μm.
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target for developing Alzheimer’s disease therapeutics
[22]. On the other hand, the activity of gamma-secretase
inhibitors for inhibiting Notch signaling has been an obs-
tacle in the development of Alzheimer’s disease therapeu-
tics because it is associated with in vivo toxicity [22]. In
contrast, for the induction of hair cells from supporting
cells, inhibiting Notch signaling is a crucial component of
gamma-secretase inhibitor activity. With regard to clinical
application, moderate, but sufficient, activity in inhibiting
Notch signaling can be included in key issues for choosing
compounds for local application to the cochlea.
Despite the short-term and weak activity of MDL for
hair cell induction [10,16], local MDL application via a
micro-osmotic pump resulted in better hearing recovery
than did the application of the vehicle. A significantly
higher number of outer hair cells were histologically ob-
served in the MDL-treated cochleae than in the vehicle-
treated cochleae. In the present study, MDL was applied
to the damaged cochleae after hair cell loss had oc-
curred. Morphological observation of MDL-treated
cochleae demonstrated the presence of outer hair cells
lacking the connection with the cups of Deiters cells.
These findings suggest that induction of hair cells from
supporting cells contributed to hair cell preservation in
MDL-treated cochleae. However, direct evidence for
trans-differentiation of supporting cells into hair cells,
which was shown in previous studies [18,20], was not
demonstrated in the present study. MDL is also known
as a calpain inhibitor. Therefore, the protection of ori-
ginal outer hair cells may be involved in the mechanism
for hair cell preservation with the MDL treatment [23].
Actually, the difference in numbers of outer hair cells
between left and right cochleae in MDL-treated animalswas not significant. In addition, greater loss of outer hair
cells in vehicle-treated cochleae was found in comparison
with that in contralateral cochleae. These findings suggest
that direct drug application through a micro-osmotic mini
pump may causes damage on outer hair cells and that
MDL may rescue outer hair cells from damages associated
with direct drug application to the cochlea. On the other
hand, previous studies have demonstrated that cell prolifer-
ation did not contribute to an increase in hair cell numbers
with a gamma-secretase inhibitor by a bromodeoxyuridine
incorporation assay [11]. Present findings in an EdU assay
demonstrated no occurrence of cell proliferation following
MDL application. Therefore, we believe that mitosis in the
cochlear epithelia may not be involved in the mechanism
for preservation of hair cells in MDL-treated cochleae.
In the present study, local MDL application by using a
micro-osmotic pump showed limited recovery of auditory
function. DPOAE recording demonstrated no significant
increase of DP/NF levels in MDL-treated cochleae. A pos-
sible explanation is that the function of newly generated
or protected hair cells in the MDL-treated cochleae is in-
ferior to that in the normal hair cells. In a previous study
using LY411575, robust newly generated hair cells were
observed in the LY411575-treated cochlea, while the func-
tional gain of LY411575-treated cochlea was limited to
8 dB in ABR thresholds compared with controls [20].
Hair cell induction from supporting cells results in the
loss of supporting cells, which could also affect auditory
function. Present findings also demonstrated a problem
due to direct drug application via a micro-osmotic mini
pump, which affected the survival of outer hair cells. This
may be resolved by the development of drug delivery
systems using biodegradable materials. The functionality
of newly generated or preserved hair cells and the
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tion should be investigated in the near future.
The present study results indicate that the use of
topical drug application may compensate for the weak
activity in the inhibition of Notch signaling. Therefore,
compounds with weak activity in the inhibition of Notch
signaling could be candidates for the treatment of hearing
loss. The exploration of new therapeutics for Alzheimer’s
disease has led to the discovery of numerous gamma-
secretase inhibitors. The present findings encourage us to
perform additional investigations in order to find the most
appropriate one for clinical use. Together with the screen-
ing of gamma-secretase inhibitors for hearing recovery,
the development of a drug delivery system that is special-
ized for a gamma-secretase inhibitor may be necessary to
progress toward a clinical application.
Conclusions
The present results demonstrated the preservation of hair
cells and auditory function by local MDL application, indi-
cating that even gamma-secretase inhibitors with a low ac-
tivity for inhibiting Notch signaling may be candidates for
the treatment of acute SNHL when appropriate drug de-
livery is achieved.
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